Stivarga 40 MG tablet 21S
Ended Awarded
- Contract number
- SPE2DR26FFBJ6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,429
Award facts
- Contract value 100% obligated
- $31,429.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On November 5, 2025, the Defense Logistics Agency awarded a $31,429.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stivarga 40 mg tablets (21-count packaging). This delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is performing under its recently awarded Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) single-award indefinite delivery contract (SPE2DR), which carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning the company as a regional prime vendor within the broader $30.3 billion PPV-G GEN V acquisition strategy established to support Department of Defense military healthcare operations globally.
DMS Pharmaceutical Group Inc. serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide. The company's established performance across numerous delivery orders spanning diverse therapeutic categories—including oncology treatments, immunosuppressants, emergency medications, and specialty pharmaceuticals—demonstrates its capability to fulfill the specialized requirements of the federal military medical system. The delivery order is scheduled for ultimate completion on November 6, 2025, with performance occurring at the contractor's headquarters in Park Ridge, Illinois.
Quick answers
Who was awarded contract SPE2DR26FFBJ6?
SPE2DR26FFBJ6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FFBJ6 worth?
The government has obligated $31,429 on SPE2DR26FFBJ6.
Is contract SPE2DR26FFBJ6 an order under another contract?
Yes. SPE2DR26FFBJ6 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBJ6 competed?
The extent of competition for SPE2DR26FFBJ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award